[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content
Springer Nature Link
Log in

Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Withdrawal symptoms stand as a core feature of alcohol dependence. Our previous results have shown that inhibition of phosphodiesterase-4 (PDE4) decreased ethanol seeking and drinking in alcohol-preferring rodents. However, little is known about whether PDE4 is involved in ethanol abstinence-related behavior.

Objective

The objective of this study was to characterize the role of PDE4 in the development of anxiety- and depressive-like behavior induced by abstinence from ethanol exposure in different animal models.

Methods

Using three rodent models of ethanol abstinence, we examined the effects of rolipram, a prototypical, selective PDE4 inhibitor, on (1) anxiety-like behavior induced by repeated ethanol abstinence in the elevated plus maze test in fawn-hooded (FH/Wjd) rats, (2) anxiety-like behavior in the open-field test and light-dark transition test following acute ethanol abstinence in C57BL/6J mice, and (3) anxiety- and depressive-like behavior induced by protracted ethanol abstinence in the elevated plus maze, forced-swim, and tail-suspension tests in C57BL/6J mice.

Results

Pretreatment with rolipram (0.1 or 0.2 mg/kg) significantly increased entries and time spent in the open arms of the elevated plus maze test in rats with repeated ethanol abstinence. Similarly, in mice with acute ethanol abstinence, administration of rolipram (0.25 or 0.5 mg/kg) dose-dependently increased the crossings in the central zone of the open-field test and duration and transitions on the light side of the light-dark transition test, suggesting anxiolytic-like effects of rolipram. Consistent with these, chronic treatment with rolipram (0.1, 0.3, or 1.0 mg/kg) increased entries in the open arms of the elevated plus maze test; it also reduced the increased duration of immobility in both the forced-swim and tail-suspension tests in mice after protracted ethanol abstinence, suggesting antidepressant-like effects of rolipram.

Conclusions

These results provide the first demonstration for that PDE4 plays a role in modulating the development of negative emotional reactions associated with ethanol abstinence, including anxiety and depression. PDE4 inhibitors may be a novel class of drugs for treatment of alcoholism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5., 5th ed, American Psychiatric Association,

  • Bell RL, Lopez MF, Cui C, Egli M, Johnson KW, Franklin KM, Becker HC (2015) Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence. Addict Biol 20:38–42

    Article  CAS  PubMed  Google Scholar 

  • Blednov YA, Benavidez JM, Black M, Harris RA (2014) Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice. Front Neurosci 8:129

    Article  PubMed  PubMed Central  Google Scholar 

  • Cherry JA, Davis RL (1999) Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol 407:287–301

  • De Witte P, Pinto E, Ansseau M, Verbanck P (2003) Alcohol and withdrawal: from animal research to clinical issues. Neurosci Biobehav Rev 27:189–197

    Article  PubMed  Google Scholar 

  • Fleischhacker WW, Hinterhuber H, Bauer H, Pflug B, Berner P, Simhandl C, Wolf R, Gerlach W, Jaklitsch H, Sastre-y-Hernandez M, Et A (1992) A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. Neuropsychobiology 26:59–64

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez-Cuello A, Sanchez L, Hernandez J, Teresa CM, Victoria MM, Laorden ML (2007) Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart. Eur J Pharmacol 570:1–9

    Article  CAS  PubMed  Google Scholar 

  • Hamdy MM, Mamiya T, Noda Y, Sayed M, Assi AA, Gomaa A, Yamada K, Nabeshima T (2001) A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice. Behav Brain Res 118:85–93

    Article  CAS  PubMed  Google Scholar 

  • Hebenstreit GF, Fellerer K, Fichte K, Fischer G, Geyer N, Meya U, Sastre-y-Hernandez M, Schony W, Schratzer M, Soukop W, Et A (1989) Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine. Pharmacopsychiatry 22:156–160

    Article  CAS  PubMed  Google Scholar 

  • Hu W, Lu T, Chen A, Huang Y, Hansen R, Chandler LJ, Zhang HT (2011) Inhibition of phosphodiesterase-4 decreases ethanol intake in mice. Psychopharmacology 218:331–339

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Iyo M, Bi Y, Hashimoto K, Inada T, Fukui S (1996) Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram. Eur J Pharmacol 312:163–170

    Article  CAS  PubMed  Google Scholar 

  • Iyo M, Maeda Y, Inada T, Kitao Y, Sasaki H, Fukui S (1995) The effects of a selective cAMP phosphodiesterase inhibitor, rolipram, on methamphetamine-induced behavior. Neuropsychopharmacology 13:33–39

    Article  CAS  PubMed  Google Scholar 

  • Janes AC, Kantak KM, Cherry JA (2009) The involvement of type IV phosphodiesterases in cocaine-induced sensitization and subsequent pERK expression in the mouse nucleus accumbens. Psychopharmacology 206:177–185

    Article  CAS  PubMed  Google Scholar 

  • Kim HJ, Park SD, Lee RM, Lee BH, Choi SH, Hwang SH, Rhim H, Kim HC, Nah SY (2017) Gintonin attenuates depressive-like behaviors associated with alcohol withdrawal in mice. J Affect Disord 215:23–29

    Article  PubMed  Google Scholar 

  • Knapp CM, Foye MM, Ciraulo DA, Kornetsky C (1999) The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration. Pharmacol Biochem Behav 62:151–158

    Article  CAS  PubMed  Google Scholar 

  • Knapp DJ, Overstreet DH, Breese GR (2007) Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal. Alcohol Clin Exp Res 31:582–595

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Koob GF (2003) Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27:232–243

    Article  CAS  PubMed  Google Scholar 

  • Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52–58

    Article  CAS  PubMed  Google Scholar 

  • Lai M, Zhu H, Sun A, Zhuang D, Fu D, Chen W, Zhang HT, Zhou W (2014) The phosphodiesterase-4 inhibitor rolipram attenuates heroin-seeking behavior induced by cues or heroin priming in rats. Int J Neuropsychopharmacol 17:1397–1407

    Article  CAS  PubMed  Google Scholar 

  • Lee GA, Forsythe M (2011) Is alcohol more dangerous than heroin? The physical, social and financial costs of alcohol. Int Emerg Nurs 19:141–145

    Article  CAS  PubMed  Google Scholar 

  • Li YF, Huang Y, Amsdell SL, Xiao L, O'Donnell JM, Zhang HT (2009) Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 34:2404–2419

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liddie S, Anderson KL, Paz A, Itzhak Y (2012) The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice. J Psychopharmacol 26:1375–1382

    Article  CAS  PubMed  Google Scholar 

  • Mizokawa T, Kimura K, Ikoma Y, Hara K, Oshino N, Yamamoto T, Ueki S (1988) The effect of a selective phosphodiesterase inhibitor, rolipram, on muricide in olfactory bulbectomized rats. Jpn J Pharmacol 48:357–364

    Article  CAS  PubMed  Google Scholar 

  • Moonat S, Starkman BG, Sakharkar A, Pandey SC (2010) Neuroscience of alcoholism: molecular and cellular mechanisms. Cell Mol Life Sci 67:73–88

    Article  CAS  PubMed  Google Scholar 

  • Nunez C, Gonzalez-Cuello A, Sanchez L, Vargas ML, Milanes MV, Laorden ML (2009) Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus. Eur J Pharmacol 620:1–8

    Article  CAS  PubMed  Google Scholar 

  • Nutt DJ, King LA, Phillips LD (2010) Drug harms in the UK: a multicriteria decision analysis. Lancet 376:1558–1565

    Article  PubMed  Google Scholar 

  • Overstreet DH, Knapp DJ, Breese GR (2002) Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcohol Clin Exp Res 26:1259–1268

    Article  PubMed  PubMed Central  Google Scholar 

  • Overstreet DH, Knapp DJ, Breese GR (2005) Pharmacological modulation of repeated ethanol withdrawal-induced anxiety-like behavior differs in alcohol-preferring P and Sprague-Dawley rats. Pharmacol Biochem Behav 81:122–130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Overstreet DH, Rezvani AH, Djouma E, Parsian A, Lawrence AJ (2007) Depressive-like behavior and high alcohol drinking co-occur in the FH/WJD rat but appear to be under independent genetic control. Neurosci Biobehav Rev 31:103–114

    Article  CAS  PubMed  Google Scholar 

  • Pandey SC (2003) Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol Sci 24:456–460

    Article  CAS  PubMed  Google Scholar 

  • Pandey SC (2004) The gene transcription factor cyclic AMP-responsive element binding protein: role in positive and negative affective states of alcohol addiction. Pharmacol Ther 104:47–58

    Article  CAS  PubMed  Google Scholar 

  • Pandey SC, Roy A, Zhang H (2003) The decreased phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats. Alcohol Clin Exp Res 27:396–409

    Article  CAS  PubMed  Google Scholar 

  • Pandey SC, Zhang H, Roy A, Xu T (2005) Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J Clin Invest 115:2762–2773

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pérez-Torres S, Miró X, Palacios JM, Cortés R, Puigdoménech P, Mengod G (2000) Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain. J Chem Neuroanat 20(3-4):349–374

  • Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379–391

    Article  CAS  PubMed  Google Scholar 

  • Rezvani AH, Overstreet DH, Cleves M, Parsian A (2007) Further genetic characterization of the fawn-hooded (FH/Wjd) rat, an animal model of comorbid depression and alcoholism. Psychiatr Genet 17:77–83

    Article  PubMed  Google Scholar 

  • Rezvani AH, Parsian A, Overstreet DH (2002) The fawn-hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism. Psychiatr Genet 12:1–16

    Article  PubMed  Google Scholar 

  • Silvestre JS, Fernandez AG, Palacios JM (1999) Effects of rolipram on the elevated plus-maze test in rats: a preliminary study. J Psychopharmacol 13:274–277

    Article  CAS  PubMed  Google Scholar 

  • Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367–370

    Article  CAS  PubMed  Google Scholar 

  • Stevenson JR, Schroeder JP, Nixon K, Besheer J, Crews FT, Hodge CW (2009) Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice. Neuropsychopharmacology 34:1209–1222

  • Thompson BE, Sachs BD, Kantak KM, Cherry JA (2004) The type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice. Eur J Neurosci 19:2561–2568

    Article  PubMed  Google Scholar 

  • Wachtel H (1983) Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors. Neuropharmacology 22:267–272

    Article  CAS  PubMed  Google Scholar 

  • Wen RT, Zhang M, Qin WJ, Liu Q, Wang WP, Lawrence AJ, Zhang HT, Liang JH (2012) The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring fawn-hooded rats. Alcohol Clin Exp Res 36:2157–2167

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wills TA, Knapp DJ, Overstreet DH, Breese GR (2009) Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats. Alcohol Clin Exp Res 33:455–463

    Article  PubMed  Google Scholar 

  • Yoneyama N, Crabbe JC, Ford MM, Murillo A, Finn DA (2008) Voluntary ethanol consumption in 22 inbred mouse strains. Alcohol 42:149–160

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zeller E, Stief HJ, Pflug B, Sastre-y-Hernandez M (1984) Results of a phase II study of the antidepressant effect of rolipram. Pharmacopsychiatry 17:188–190

    Article  CAS  PubMed  Google Scholar 

  • Zhang C, Cheng Y, Wang H, Wang C, Wilson SP, Xu J, Zhang HT (2014) RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-beta42-induced memory deficits in mice. J Alzheimers Dis 38:269–280

    PubMed  Google Scholar 

  • Zhang HT (2009) Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs. Curr Pharm Des 15:1688–1698

    Article  CAS  PubMed  Google Scholar 

  • Zhang HT, Huang Y, Jin SL, Frith SA, Suvarna N, Conti M, O'Donnell JM (2002) Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme. Neuropsychopharmacology 27:587–595

    CAS  PubMed  Google Scholar 

  • Zhang HT, Huang Y, Masood A, Stolinski LR, Li Y, Zhang L, Dlaboga D, Jin SL, Conti M, O'Donnell JM (2008) Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology 33:1611–1623

    Article  CAS  PubMed  Google Scholar 

  • Zhong P, Wang W, Yu F, Nazari M, Liu X, Liu QS (2012) Phosphodiesterase 4 inhibition impairs cocaine-induced inhibitory synaptic plasticity and conditioned place preference. Neuropsychopharmacology 37:2377–2387

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by research grants from the National Nature Science Foundation of China (81373384, to J-PX; 81503050, to R-TW; and 30870894, to J-HL), the Natural Science Foundation of Zhejiang Province, China (LY14H310012; to J-CP), the Foundation of Overseas Distinguished Taishan Scholars of Shandong Province (to H-TZ), and China and US NIH/NIAAA (AA020042; to H-TZ).

Author information

Author notes

  1. Mei-Fang Gong, Rui-Ting Wen and Ying Xu contributed equally to this work.

Authors and Affiliations

  1. Department of Neuropharmacology and Novel Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China

    Mei-Fang Gong & Jiang-Ping Xu

  2. Department of Behavioral Medicine and Psychiatry, Blanchette Rockefeller Neurosciences Institute, West Virginia University Health Sciences Center, Morgantown, WV, 26506, USA

    Mei-Fang Gong, Rui-Ting Wen, Ying Xu & Han-Ting Zhang

  3. Department of Physiology and Pharmacology, Blanchette Rockefeller Neurosciences Institute, West Virginia University Health Sciences Center, Morgantown, WV, 26506, USA

    Mei-Fang Gong, Rui-Ting Wen, Ying Xu & Han-Ting Zhang

  4. Department of Pharmacy, Peking University People’s Hospital, Beijing, 100044, China

    Rui-Ting Wen

  5. Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, NY, 14214, USA

    Ying Xu

  6. Brain Institute, School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China

    Jian-Chun Pan & Ning Fei

  7. Institute of Pharmacology, Taishan Medical University, Taian, Shandong, 271016, China

    Yan-Meng Zhou & Han-Ting Zhang

  8. Department of Molecular and Cellular Pharmacology, Peking University School of Pharmaceutical Sciences, Beijing, 100191, China

    Jian-Hui Liang

Authors
  1. Mei-Fang Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rui-Ting Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ying Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jian-Chun Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ning Fei
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yan-Meng Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jiang-Ping Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jian-Hui Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Han-Ting Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jiang-Ping Xu, Jian-Hui Liang or Han-Ting Zhang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gong, MF., Wen, RT., Xu, Y. et al. Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents. Psychopharmacology 234, 3143–3151 (2017). https://doi.org/10.1007/s00213-017-4697-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-017-4697-3

Keywords

Search

Navigation